Human nuclear RNAi-defective 2 (NRDE2) is an essential RNA splicing factor.


Journal

RNA (New York, N.Y.)
ISSN: 1469-9001
Titre abrégé: RNA
Pays: United States
ID NLM: 9509184

Informations de publication

Date de publication:
03 2019
Historique:
received: 06 12 2018
accepted: 20 12 2018
pubmed: 13 12 2018
medline: 26 3 2019
entrez: 13 12 2018
Statut: ppublish

Résumé

The accurate inheritance of genetic material is a basic necessity in all domains of life and an unexpectedly large number of RNA processing factors are required for mitotic progression and genome stability. NRDE2 (nuclear RNAi defective-2) is an evolutionarily conserved protein originally discovered for its role in nuclear RNA interference (RNAi) and heritable gene silencing in

Identifiants

pubmed: 30538148
pii: rna.069773.118
doi: 10.1261/rna.069773.118
pmc: PMC6380277
doi:

Substances chimiques

RNA Precursors 0
RNA Splicing Factors 0
RNA, Small Interfering 0
RNA-Binding Proteins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

352-363

Subventions

Organisme : NIA NIH HHS
ID : R01 AG033921
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM088289
Pays : United States
Organisme : NIH HHS
ID : R01AG033921
Pays : United States

Informations de copyright

© 2019 Jiao et al.; Published by Cold Spring Harbor Laboratory Press for the RNA Society.

Références

Bioessays. 2014 Mar;36(3):236-43
pubmed: 24352796
EMBO Rep. 2014 Sep;15(9):956-64
pubmed: 25092792
EMBO J. 1997 Jul 1;16(13):4092-106
pubmed: 9233818
J Comput Biol. 2004;11(2-3):377-94
pubmed: 15285897
Cell Mol Life Sci. 2015 Jan;72(1):11-23
pubmed: 25173771
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5651-6
pubmed: 22451905
Cell. 2013 Feb 28;152(5):957-68
pubmed: 23415457
Cell. 2015 Dec 3;163(6):1515-26
pubmed: 26627737
Cell. 2013 Nov 21;155(5):1061-74
pubmed: 24210919
Genome Biol. 2017 Mar 15;18(1):51
pubmed: 28298237
Mol Cell. 2014 Aug 21;55(4):578-91
pubmed: 25042804
Proc Natl Acad Sci U S A. 2011 Dec 6;108(49):19683-8
pubmed: 22106253
Cell. 2012 Nov 9;151(4):750-764
pubmed: 23084401
Genome Res. 2014 Nov;24(11):1774-86
pubmed: 25258385
Dev Cell. 2017 Aug 7;42(3):241-255.e6
pubmed: 28787591
Mol Cell. 2009 Jul 31;35(2):228-39
pubmed: 19647519
Science. 2015 Nov 27;350(6264):1092-6
pubmed: 26472760
Nature. 2010 Apr 1;464(7289):721-7
pubmed: 20360735
Oncogene. 2004 Mar 25;23(13):2379-84
pubmed: 14767474
Nature. 2010 Jun 24;465(7301):1097-101
pubmed: 20543824
RNA Biol. 2018;15(7):868-876
pubmed: 29902117
EMBO Rep. 2014 Sep;15(9):948-55
pubmed: 25092791
Genes Dev. 2017 Jun 15;31(12):1257-1271
pubmed: 28733371
Nat Med. 2018 May;24(4):497-504
pubmed: 29457796
Nat Commun. 2015 May 20;6:7050
pubmed: 25989903
Cold Spring Harb Perspect Biol. 2011 Feb 01;3(2):
pubmed: 20926517
Dev Cell. 2004 Feb;6(2):253-68
pubmed: 14960279
Open Biol. 2013 Mar 20;3(3):120185
pubmed: 23516109
J Cell Sci. 2012 Oct 15;125(Pt 20):4770-9
pubmed: 22797915
Nucleic Acids Res. 2016 Feb 29;44(4):1703-17
pubmed: 26682798
EMBO J. 2014 Nov 18;33(22):2643-58
pubmed: 25257309
Mol Cell. 2011 Aug 19;43(4):624-37
pubmed: 21855801
Nat Commun. 2017 Mar 31;8:14866
pubmed: 28361952
Science. 2007 Apr 20;316(5823):417-21
pubmed: 17412918
RNA. 2016 Sep;22(9):1411-26
pubmed: 27365209
Nat Cell Biol. 2011 Oct 03;13(10):1154-60
pubmed: 21968988
Curr Biol. 2007 Nov 20;17(22):1960-6
pubmed: 17980596
Science. 2013 Feb 15;339(6121):819-23
pubmed: 23287718
Nature. 2015 Jun 11;522(7555):179-84
pubmed: 26017310
Mol Biol Cell. 2015 Sep 1;26(17):2957-62
pubmed: 26316498
Cell. 2013 Sep 12;154(6):1380-9
pubmed: 23992846

Auteurs

Alan L Jiao (AL)

HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Department of Molecular, Cellular, and Developmental Biology, Yale University, New Haven, Connecticut 06511, USA.

Roberto Perales (R)

Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.

Neil T Umbreit (NT)

Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.

Jeffrey R Haswell (JR)

HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.
Department of Biological and Biomedical Sciences, Harvard University, Boston, Massachusetts 02115, USA.

Mary E Piper (ME)

Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts 02115, USA.

Brian D Adams (BD)

HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA.

David Pellman (D)

Department of Cell Biology, Harvard Medical School, Boston, Massachusetts 02115, USA.
Department of Pediatric Oncology, Dana-Farber Cancer Institute and Pediatric Hematology/Oncology, Boston Children's Hospital, Boston, Massachusetts 02215, USA.
Howard Hughes Medical Institute, Chevy Chase, Maryland 20815, USA.

Scott Kennedy (S)

Department of Genetics, Harvard Medical School, Boston, Massachusetts 02115, USA.

Frank J Slack (FJ)

HMS Initiative for RNA Medicine, Department of Pathology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215, USA fslack@bidmc.harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH